Epidemiology
A section of Vaccines (ISSN 2076-393X).
Section Information
Aims
Vaccine epidemiology concerns the interactions and effects of vaccines (and vaccination programs) on the occurrence of vaccine-preventable diseases.
Scope
There is increasing recognition that vaccines are proven lifesaving interventions, and application of epidemiological principles maximizes the benefits of this type of primary prevention.
Thus, manuscripts investigating the infectivity, vaccine efficacy and effectiveness, vaccine failure, herd immunity, herd effect, epidemiological transfer, and disease modeling of various epidemics will be considered for submission.
In addition, vaccine epidemiology considers the viewpoints of major stakeholders, including decision makers, immunization program managers, public health experts, pediatricians, family doctors, and other experts/individuals involved in the provision of immunization services and those who conduct research on awareness and behaviors surrounding vaccine epidemiology.
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Future of Epidemic and Pandemic Vaccines to Serve Global Public Health Needs (Deadline: 30 June 2024)
- Vaccines and Vaccination: Historical Perspectives, Current Issues and Emerging/Evolving Themes (Deadline: 30 June 2024)
- Progress on Antiviral Drugs Research in Epidemics (Deadline: 25 July 2024)
- COVID-19 Disparities and Vaccine Equity (Deadline: 31 July 2024)
- Precision Vaccinology for Public Health (Deadline: 30 September 2024)
- SARS-CoV-2, Influenza and Other Respiratory Viruses: Epidemiology, Burden of Disease, and Preventive Measures (Deadline: 30 September 2024)
- Immunology and Epidemiology of Infectious Diseases and Infection (Deadline: 10 October 2024)
- Infectious Diseases: Importance for Public Health, Epidemiology, Promoting Factors, and Vaccines Prevention (Deadline: 30 November 2024)
- Vaccines against Mpox: Combating the Threat (Deadline: 15 December 2024)
- Influence of Natural and/or Vaccine Immunity on the Dynamics of SARS-CoV-2 (Deadline: 31 December 2024)